Combination of Atezolizumab and Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma and Diffuse Large B‐Cell Lymphoma: Results from a Phase 1b Study
Title:
Combination of Atezolizumab and Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma and Diffuse Large B‐Cell Lymphoma: Results from a Phase 1b Study
Author:
Palomba, M. Lia Till, Brian G. Park, Steven I. Morschhauser, Franck Cartron, Guillaume Marks, Reinhard Shivhare, Mahesh Hong, Wan-Jen Raval, Aparna Chang, Alice C. Penuel, Elicia Popplewell, Leslie L.